These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29630491)

  • 1. A longitudinal study assessing depression in hepatitis C: Does gender play a role in the new-onset depression during interferon-alpha treatment?
    Fialho R; Pereira M; Gilleece Y; Rusted J; Whale R
    Women Health; 2019 Feb; 59(2):181-195. PubMed ID: 29630491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C.
    Fialho R; Pereira M; Harrison N; Rusted J; Whale R
    Psychiatry Res; 2017 Jul; 253():150-157. PubMed ID: 28365538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus.
    Wackernah RC; Lou M; Park SH
    Clin Ther; 2011 Oct; 33(10):1400-5. PubMed ID: 21982383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder.
    Su KP; Lai HC; Peng CY; Su WP; Chang JP; Pariante CM
    Brain Behav Immun; 2019 Aug; 80():512-518. PubMed ID: 31059806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
    Reichenberg A; Gorman JM; Dieterich DT
    AIDS; 2005 Oct; 19 Suppl 3():S174-8. PubMed ID: 16251815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.
    Loftis JM; Wall JM; Linardatos E; Benvenga S; Hauser P
    J Endocrinol Invest; 2004; 27(7):RC16-20. PubMed ID: 15505982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C.
    Belvederi Murri M; Cecere AC; Masotti M; Sammito G; la Marca A; Torres GV; Bonfitto I; Cuozzo E; Rossi L; Serviddio G; Villani R; Picciotto A; Bellomo A; Amore M
    Asian J Psychiatr; 2017 Apr; 26():24-28. PubMed ID: 28483085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
    Vabo IL; Ferreira LE; Pace FH
    Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Małyszczak K; Inglot M; Frydecka D; Hadryś T; Pawłowski T
    Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
    Whale R; Fialho R; Rolt M; Eccles J; Pereira M; Keller M; File A; Haq I; Tibble J
    J Psychosom Res; 2015 Dec; 79(6):640-5. PubMed ID: 26117091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Mahajan S; Avasthi A; Grover S; Chawla YK
    J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
    Morasco BJ; Rifai MA; Loftis JM; Indest DW; Moles JK; Hauser P
    J Affect Disord; 2007 Nov; 103(1-3):83-90. PubMed ID: 17292481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
    Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.
    Sundberg I; Lannergård A; Ramklint M; Cunningham JL
    BMC Psychiatry; 2018 May; 18(1):157. PubMed ID: 29843679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent pro-inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment-induced depression.
    Krueger C; Hawkins K; Wong S; Enns MW; Minuk G; Rempel JD
    J Viral Hepat; 2011 Jul; 18(7):e284-91. PubMed ID: 21143344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
    Kikuchi K; Akiba T; Nitta K; Masakane I; Ando R; Izumi N; Atsukawa M; Yamazaki C; Kato F; Hotta N; Tominaga Y; Orito E; Hora K; Nagasawa M; Kasahara H; Kawaguchi M; Kimura H; Ikebe N; Kawanishi H; Moriishi M; Shigemoto K; Harada T; Hirakata H; Watanabe H; Nosaki T; Tsubouchi H; Imawari M; Akizawa T
    Ther Apher Dial; 2014 Dec; 18(6):603-11. PubMed ID: 25196061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review.
    Machado MO; Oriolo G; Bortolato B; Köhler CA; Maes M; Solmi M; Grande I; Martín-Santos R; Vieta E; Carvalho AF
    J Affect Disord; 2017 Feb; 209():235-245. PubMed ID: 27936453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.